-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

615.O1.6 615. Acute Myeloid Leukemias: Clinical and Epidemiological: Genetic Markers and Outcomes in AML

Symposia: Acute Myeloid Leukemias: Clinical and Epidemiological Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Acute Myeloid Malignancies, AML, Research, Clinical trials, Combination therapy, Epidemiology, Clinical Research, Diseases, Treatment Considerations, Real-world evidence, Myeloid Malignancies, Study Population, Human, Measurable Residual Disease
Monday, December 9, 2024: 2:45 PM-4:15 PM
Grand Hall C (Manchester Grand Hyatt San Diego)
Moderators:
Daniel R Reed, MD, University of Virginia Medical Center Comprehensive Cancer Center and Aman Wadhwa, MD,
Disclosures:
No relevant conflicts of interest to declare.
2:45 PM

Sankalp Arora, MBBS1, Musa Yilmaz, MD2*, Wei-Ying Jen, MD, FRCPath, MA2*, Nicholas J. Short, MD2, Sanam Loghavi, MD3, Tapan M. Kadia, MD2, Courtney D. DiNardo, MD, MSc4, Gautam Borthakur, MD5, Indraneel Deshmukh, MBBS, MPH6*, Ghayas C. Issa, MD2, Joseph E. Jabbour7*, Naveen Pemmaraju, MD8, Michael Andreeff, MD, PhD5, Koichi Takahashi, MD, PhD9, Kapil N. Bhalla, MD6, Hussein A. Abbas, MD, PhD2, Guillermo Garcia-Manero, MD2, Farhad Ravandi, MBBS10, Hagop M. Kantarjian, MD2 and Naval Daver, MD11

1Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
3Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
4Department of Leukemia, UT MD Anderson Cancer Center, Houston, TX
5Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
6UT MD Anderson Cancer Center, Houston, TX
7Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
8Department of Leukemia, The University of Texas MD Anderson Cancer Center, Bellaire, TX
9Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
10Department of Leukemia, University of Texas- MD Anderson Cancer Center, Houston, TX
11MD Anderson Cancer Center, Houston, TX

3:00 PM

Vikram Dhillon, DO, MBA1,2*, Jeff Aguilar, MD, MBA3*, Paul Kim, BA4*, Dakshin Padmanabhan, MBBS5, Jay Yang, MD6, Gregory Dyson, PhD7*, David Carr, MD6*, Jaroslaw Maciejewski8 and Suresh Kumar Balasubramanian, MD9,10

1Department of Oncology, Karmanos Cancer Center/Wayne State University, Detroit, MI
2Department of Hematology/Oncology, Neal Cancer Center/Houston Methodist Hospital, Houston, TX
3Department of Oncology, Karmanos Cancer Institute/Wayne State University, Windsor, ON, Canada
4Karmanos Cancer Institute/Wayne State University, Detroit, MI
5Internal Medicine, Trinity Health Oakland Hospital, Rochester Hills, MI
6Department of Oncology, Karmanos Cancer Institute/Wayne State University, Detroit, MI
7Karmanos Cancer Institute/Department of Oncology, Wayne State University, Detroit, MI
8Taussig Cancer Center, Cleveland, OH
9Department of Oncology, Karmanos Cancer Institute/Wayne State University, Troy, MI
10Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH

3:15 PM

Yibo Wu, MD1,2,3*, Xiaolin Yuan, MD1,2,3*, Xiaoyu Lai, MD4*, Lizhen Liu, MD5*, Jimin Shi1*, Weiyan Zheng, MD4*, Jian Yu, MD1*, Yanmin Zhao, MD5*, Jie Sun, PhD6*, Xiujin Ye1*, Zhen Cai1*, He Huang, MD1*, Shanshan Pei, PhD1* and Yi Luo3,5,7

1Bone Marrow Transplantation Center of The First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, hangzhou, China
2Zhejiang Province Engineering Research Center for Stem Cell and Immunity Therapy, hangzhou, China
3Institute of Hematology, Zhejiang University, hangzhou, China
4Bone Marrow Transplantation Center of The First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, Hangzhou, China
5Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
6Bone Marrow Transplantation Center of The First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
7Zhejiang Province Engineering Research Center for Stem Cell and Immunity Therapy, Hangzhou, China

3:30 PM

Rabea Mecklenbrauck, MD1,2*, Angela Villaverde Ramiro3*, Eric Sträng, PhD4*, Razif Gabdoulline1*, Javier Martínez Elicegui3*, Marta Sobas, MD5*, Lisa Pleyer, MD6*, Maria Teresa Voso, MD7, Axel Benner8*, Alberto Hernández Sánchez, MD9*, Jesse M. Tettero, MD, PhD10*, Laura Tur11*, Klaus H Metzeler, MD12, Guadalupe Onate, MD, PhD13*, Soren Lehmann, MD, PhD14*, Brian J P Huntly, MD15*, Ian Thomas16*, Felicitas R Thol, MD1, Florian Heidel, MD1, Peter J. M. Valk, PhD17, Konstanze Döhner, MD18, Torsten Haferlach, MD19, Ken I Mills, PhD, FRCPath20, Hartmut Döhner, MD18, Gastone Castellani, PhD21*, Gert Ossenkoppele, MD10*, Jesus Maria Hernandez Rivas, MD9, Lars Bullinger4 and Michael Heuser, MD1,22

1Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany
2MRC Molecular Haematology Unit, Radcliffe Department of Medicine, Weatherall Institute of Medicine, University of Oxford, Oxford, United Kingdom
3Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain
4Department of Hematology, Oncology, Tumor Immunology, Charité University Medicine, Berlin, Germany
5Department of Hematology, Blood Neoplasms and Bone Marrow Transplantation, Medical University of Wroclaw, Wroclaw, Poland
63rd Medical Dept. with Haematology, Medical Oncology, Haemostaseology, Rheumatology and Infectiology, Oncologic Center, Paracelsus Medical University, Salzburg, Austria
7Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy
8Division of Biostatistics, German Cancer Research Center (DKFZ), Heidelberg, Germany
9Hematology Department, Hospital Universitario de Salamanca (CAUSA/IBSAL), Salamanca, Spain
10Department of Hematology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, Netherlands
11GMV Innovating Solutions, Valencia, Spain
12Department for Hematology, Cell Therapy, Hemostaseology and Infectious Diseases, University of Leipzig Medical Center, Leipzig, Germany
13Hematology Department, Hospital Santa Creu i Sant Pau, Barcelona, Spain
14Center for Hematology and Regenerative Medicine, Department of Medicine Huddinge, Karolinska Institute, Stockholm, Sweden
15Department of Haematology and Cambridge Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom
16Centre for Trials Research, Cardiff University, Cardiff, United Kingdom
17Erasmus University Medical Center, Rotterdam, Netherlands
18Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany
19MLL Munich Leukemia Laboratory, Munich, Germany
20Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, NI, United Kingdom
21Dipartimento di Scienze Mediche e Chirurgiche, Università di Bologna, Bologna, Italy
22Department of Internal Medicine IV, University Hospital Halle (Saale), Halle (Saale), Germany

3:45 PM

Jad Othman, FRACP, FRCPA, MBBS1,2, Nicola Potter, PhD2*, Sylvie D Freeman3, Nicholas McCarthy4*, Jelena Jovanovic, PhD5*, Manohursingh Runglall6*, Joanna Canham7*, Ian Thomas8*, Sean Johnson9*, Jamie Cavenagh10*, Panagiotis Kottaridis, FRCPath, PhD, MSc11*, David Taussig, PhD, MRCP, FRCPath12, Claire Arnold13*, Claire Hemmaway14*, Dominic J. Culligan, MD, FRCP, FRCPath, BSc, MBBS15*, Ulrik Malthe Overgaard16*, Alan K. Burnett, MD17*, Mike Dennis, MD, MRCP, FRCPath18, Richard Dillon, MA19,20 and Nigel H. Russell, MD1

1Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom
2Department of Medical and Molecular Genetics, King's College London, London, United Kingdom
3University of Birmingham, Birmingham, United Kingdom
4University of Birmingham, UK, Birmingham, GBR
5King’s College London, London, United Kingdom
6King's College, London, London, GBR
7Cardiff University, Cardiff, WAL, GBR
8Centre for Trials Research, Cardiff University, Cardiff, United Kingdom
9Cardiff University, Cardiff, United Kingdom
10St. Bartholomew's Hospital London, London, United Kingdom
11University College London Hospitals, London, United Kingdom
12The Royal Marsden Hospital and Institute of Cancer Research, London, United Kingdom
13Belfast City Hospital, Belfast, United Kingdom
14Auckland City Hospital, Auckland, NZL
15Aberdeen Royal Infirmary, NHS Grampian, Aberdeen, United Kingdom
16Department of Hematology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark
17Paul O’Gorman Leukaemia Centre, Glasgow University, Glasgow, United Kingdom
18The Christie NHS Foundation Trust, Manchester, United Kingdom
19Guy's and St. Thomas' NHS Foundation Trust, London, ENG, United Kingdom
20Department of Medical and Molecular Genetics, King's College, London, United Kingdom

4:00 PM

Mael Heiblig1*, Gaspar Aspas Requena2*, Urbain Tauveron-Jalenques2*, Emmanuelle Tavernier, MD3*, Jérome Cornillon, MD4*, Martin Carre, MD5*, Mathieu Meunier6*, Ugo Thévenet, MD7*, Boullanger Fow Heng Nadine8*, Clémence Santana9*, Clément Rocher, MD10*, Sylvain Lamure, MD, PhD11*, Amine Belhabri, MD12*, Mauricette Michallet, MD, PhD12, Adrien Contejean13*, Natacha Mauz13*, Gian Matteo Pica, MD14*, Arthur Dony14* and Zofia Gross, MD15*

1Service d'hématologie clinique, Hospices Civils de Lyon, Hôpital Lyon Sud, Pierre-Bénite, France
2Département d'Hématologie, CHU de Clermont-Ferrand, Clermont-Ferrand, France
3Institut De Cancérologie De La Loire, Saint Priest En Jarez, FRA
4Institut Cancerologique De La Loire, Saint-priest-en-Jarez, FRA
5Clinical Hematology Department, CHU Grenoble Alpes - Université Grenoble Alpes, Grenoble, France
6Department of Hematology CHU Grenoble Alpes, Grenoble, France
7CH de Roanne, Roanne, France
8Département d'hématologe, CH Roanne, Roanne, France
9Département d'Hématologie, CH de Valence, Valence, France
10Département d'Hématologie, Centre Hospitalier Bourgoin Jallieu, Bourgoin Jallieu, France
11Département d'Onco-Hématologie, Hôpitaux Nord-Ouest, Villefranche-sur-Saone, France
12Département de Cancérologie médicale, Centre Léon Bérard, Lyon, France
13Département d'Hématologie, Centre Hospitalier Annecy Genevois, Epagny Metz-Tessy, France
14Département d'Hématologie, CH Chambery, Chambéry, France
15Département d'Hématologie, CHU de Lyon, Pierre-Bénite, France

*signifies non-member of ASH